2
h-index
2
Publications
3,683
Citations

Publications

2 shown

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

Howard West , Michael McCleod , Maen Hussein +17 more

Atezolizumab (a monoclonal antibody against PD-L1), which restores anticancer immunity, improved overall survival in patients with previously treated non-small-cell lung cancer ...

2019 The Lancet Oncology 1597 citations

Frequent Co-Authors

Researcher Info

h-index
2
Publications
2
Citations
3,683
Institution
AstraZeneca (United Kingdom)

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.